Results
|
|
2941.
|
|
|
|
2942.
|
|
|
|
2943.
|
|
|
|
2944.
|
|
|
|
2945.
|
|
|
|
2946.
|
|
|
|
2947.
|
|
|
|
2948.
|
|
|
|
2949.
|
|
|
|
2950.
|
|
|
|
2951.
|
|
|
|
2952.
|
|
|
|
2953.
|
|
|
|
2954.
|
|
|
|
2955.
|
|
|
|
2956.
|
|
|
|
2957.
|
|
|
|
2958.
|
|
|
|
2959.
|
|
|
|
2960.
|
Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial. [electronic resource] by
- Mori, Masaaki
- Hara, Takuma
- Kikuchi, Masako
- Shimizu, Hiroyuki
- Miyamoto, Tomoyuki
- Iwashima, Satoru
- Oonishi, Tatsuya
- Hashimoto, Kunio
- Kobayashi, Norimoto
- Waki, Kenji
- Suzuki, Yasuo
- Otsubo, Yoshikazu
- Yamada, Hiroshi
- Ishikawa, Chikao
- Kato, Taichi
- Fuse, Shigeto
Producer: 20181211
In:
Scientific reports vol. 8
Availability: No items available.
|